What is Sanofi - ADR Quarterly Revenue?

Sanofi - ADR Quarterly Revenue Sanofi - ADR Dec-2024 Quarterly Revenue is $7,631 Million which is growth of -37.5% YoY.

What is Sanofi - ADR Quarterly Net Profit?

Sanofi - ADR Quarterly Net Profit Sanofi - ADR Dec-2024 Quarterly Net Profit is $499 Million which is growth of 189.9% YoY.

What is Sanofi - ADR Annual Revenue?

Sanofi - ADR Annual Revenue Sanofi - ADR Dec-2024 Annual Revenue is $44,286 Million which is growth of -4.6% YoY.

What is Sanofi - ADR Annual Net Profit?

Sanofi - ADR Annual Net Profit Sanofi - ADR Dec-2024 Annual Net Profit is $5,560 Million which is growth of 3.0% YoY.

What is Sanofi - ADR Total Shareholders Fund?

Sanofi - ADR Total Shareholders Fund Sanofi - ADR Dec-2024 Total Shareholders Fund is $77,507 Million which is growth of 4.7% YoY.

What is Sanofi - ADR Total Assets?

Sanofi - ADR Total Assets Sanofi - ADR Dec-2024 Total Assets is $132,798 Million which is growth of 5.0% YoY.

What is Sanofi - ADR Book Value Per Share?

Sanofi - ADR Book Value Per Share Sanofi - ADR Book Value Per Share is $34 which is growth of 8.9% YoY.

What is Sanofi - ADR ROE?

Sanofi - ADR ROE Sanofi - ADR ROE is 7% which is growth of 0.1% YoY.

What is Sanofi - ADR Cash From Operating Activity?

Sanofi - ADR Cash From Operating Activity Sanofi - ADR Dec-2024 Cash From Operating Activity is $8,607 Million which is growth of -16.1% YoY.

What is Sanofi - ADR Net Cash Flow?

Sanofi - ADR Net Cash Flow Sanofi - ADR Dec-2024 Net Cash Flow is $-1,442 Million which is growth of 63.9% YoY.

What is Sanofi - ADR Annual Revenue?

Sanofi - ADR Annual Revenue rose 6.41%, in the last year to $44,286 M. Its sector's average revenue growth for the last fiscal year was 7.54%.

What is Sanofi - ADR Annual Net Profit?

Sanofi - ADR Annual Net Profit rose 2.96% in the last year to $5,560 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

What is Sanofi - ADR Price to Earning Ratio?

Sanofi - ADR Price to Earning Ratio is 19.62, higher than its sector PE ratio of 3.22.

What is Sanofi - ADR Stock Price?

Sanofi - ADR Stock Price rose 9.94% and outperformed its sector by 2.61% in the past year.

What is Sanofi - ADR Quarterly Revenue?

Sanofi - ADR Quarterly Revenue rose 3.47% YoY to $7,631 M. Its sector's average revenue growth YoY for the quarter was 5.84%.

What is Sanofi - ADR Quarterly Net profit?

Sanofi - ADR Quarterly Net profit rose 189.91% YoY to $499 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

What is Sanofi - ADR Debt to Equity Ratio?

Sanofi - ADR Debt to Equity Ratio of 0.23 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Sanofi - ADR Return on Equity(ROE)?

Sanofi - ADR Return on Equity(ROE) for the last financial year was 7.34%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Sanofi - ADR Mutual Fund Holding?

Sanofi - ADR Mutual Fund Holding increased by 0.17% in the last quarter to 5.91.

What is Sanofi - ADR Interest Coverage Ratio?

Sanofi - ADR Interest Coverage Ratio is 9.94, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Sanofi - ADR Institutional Holding?

Sanofi - ADR Institutional Holding increased by 0.02% in the last quarter to 10.64.

How is the Sanofi - ADR today?

The Sanofi - ADR today is trading in the green, up by 0.67% at 50.90.

How has Sanofi - ADR performed historically?

The Sanofi - ADR is currently trading up 0.67% on an intraday basis in the past week the index fell -1.17%. The index has been up 0.32% in the past quarter and rose 9.94% in the past year. You can view this in the overview section.

Sanofi - ADR XNAS: SNY

Sanofi - ADR Live Share Price Today, Share Analysis and Chart

Name: Sanofi - ADR: Is Infosys Ltd. worth buying?
Item: Sanofi - ADR
Rating: 2.208194375
Author: Trendlyne DVM scores

Mid-range Performer

Download real time

50.90 0.34 (0.67%)

2.8M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Dividend

Sanofi - ADR has an upcoming dividend of $2.21 per share due on 09 May 2025 See details

Sanofi - ADR Key Metrics

My Metrics

Select

Market Capitalization High in industry Unavailable in chosen country	124,313.7
PE TTM High in industry Unavailable in chosen country	19.6
PEG TTM High in industry Unavailable in chosen country	6.6
Price to Book Below industry Median Unavailable in chosen country	1.3
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	10.6
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	3.5
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	6.4
Net Profit Qtr Growth YoY % High in industry Unavailable in chosen country	189.9
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	3
Operating Profit Margin Qtr % Below industry Median Unavailable in chosen country	11.3
Operating Profit Margin TTM % High in industry Unavailable in chosen country	21.4
Piotroski Score High in industry Unavailable in chosen country	6
Rel Perf vs Sector quarter% Unavailable in chosen country	1.3
ROE Annual % High in industry Unavailable in chosen country	7.3
RoA Annual % High in industry Unavailable in chosen country	4.3

All financials are in EUR Million and price data in USD

Medium Financial Strength

44.4 / 100

Mid Valuation

45.7 / 100

Technically Neutral

42.1 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

1Yr Price target upside is 26%

9 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Buy Zone

32.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Sanofi - ADR Stock Price Analysis

Day Price Range 0.7% 1 Day return Unavailable in chosen country	50.9 (LTP) 50.951.6 LowHigh
Week Price Range -1.2% 1 Week return Unavailable in chosen country	50.9 (LTP) 50.452.2 LowHigh
Month Price Range -13.1% 1 Month return Unavailable in chosen country	50.9 (LTP) 47.758.2 LowHigh
52 Week Price Range 9.9% 1 Year return Unavailable in chosen country	50.9 (LTP) 45.860.1 LowHigh

View full Share Price History

Sanofi - ADR Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

Sanofi - ADR's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

2.4

Avg. Estimate

Low Estimate

3.6

High Estimate

8.4

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 150.6% in FY25

Consensus Recommendation

10 ANALYST Recommendations

BUY

The consensus recommendation from 10 analysts for Sanofi - ADR is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Sanofi - ADR Stock Analysis

Sanofi - ADR stock analysis with key metrics, changes, and trends.

Sanofi - ADR Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$44,286 M	6.41%	positive	Annual Revenue rose 6.41%, in the last year to $44,286 M. Its sector's average revenue growth for the last fiscal year was 7.54%.
Annual Net Profit	$5,560 M	2.96%	positive	Annual Net Profit rose 2.96% in the last year to $5,560 M. Its sector's average net profit growth for the last fiscal year was -30.36%.
Price to Earning Ratio	19.62	-	negative	Price to Earning Ratio is 19.62, higher than its sector PE ratio of 3.22.
Stock Price	$50.90	9.94%	positive	Stock Price rose 9.94% and outperformed its sector by 2.61% in the past year.
Quarterly Revenue	$7,631 M	3.47%	positive	Quarterly Revenue rose 3.47% YoY to $7,631 M. Its sector's average revenue growth YoY for the quarter was 5.84%.
Quarterly Net profit	$499 M	189.91%	positive	Quarterly Net profit rose 189.91% YoY to $499 M. Its sector's average net profit growth YoY for the quarter was -48.37%.
Debt to Equity Ratio	0.23	-	positive	Debt to Equity Ratio of 0.23 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	7.34 %	7.34%	negative	Return on Equity(ROE) for the last financial year was 7.34%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	5.91 %	0.17%	positive	Mutual Fund Holding increased by 0.17% in the last quarter to 5.91.
Interest Coverage Ratio	9.94	-	positive	Interest Coverage Ratio is 9.94, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	10.64 %	0.02%	positive	Institutional Holding increased by 0.02% in the last quarter to 10.64.

VIEW LESS

Loading data..

Sanofi - ADR - Company Profile

What does Sanofi - ADR do?

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

167.5 K

2024

Gross Remuneration

Year

Sanofi - ADR Live Share Price Today, Share Analysis and Chart

Sanofi - ADR Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Check Before You Buy

Check P/E Buy Sell Zone

Sanofi - ADR Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Sanofi - ADR Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Sanofi - ADR's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to grow by 150.6% in FY25

Consensus Recommendation

The consensus recommendation from 10 analysts for Sanofi - ADR is BUY

Sanofi - ADR Stock Analysis

Sanofi - ADR stock analysis with key metrics, changes, and trends.

Annual Revenue rose 6.41%, in the last year to $44,286 M. Its sector's average revenue growth for the last fiscal year was 7.54%.

Annual Net Profit rose 2.96% in the last year to $5,560 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

Price to Earning Ratio is 19.62, higher than its sector PE ratio of 3.22.

Stock Price rose 9.94% and outperformed its sector by 2.61% in the past year.

Quarterly Revenue rose 3.47% YoY to $7,631 M. Its sector's average revenue growth YoY for the quarter was 5.84%.

Quarterly Net profit rose 189.91% YoY to $499 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

Debt to Equity Ratio of 0.23 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 7.34%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 0.17% in the last quarter to 5.91.

Interest Coverage Ratio is 9.94, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding increased by 0.02% in the last quarter to 10.64.

Sanofi - ADR - Company Profile

What does Sanofi - ADR do?

Sanofi - ADR Management structure

Mr. Francois-Xavier Roger

Executive Vice President and Chief Financial Officer

Mr. Olivier Charmeil

Executive Vice President, General Medicines

Mr. Paul Hudson

Director and Chief Executive Officer

Mr. Jean-Baptiste Chasseloup De Chatillon

Executive Vice President and Chief Financial Officer

Ms. Natalie Bickford

Executive Vice President and Chief People Officer

Ms. Julie Van Ongevalle

Executive Vice President, Consumer Healthcare

Sanofi - ADR Board of directors

Ms. Carole Ferrand

Independent Director

Mr. Patrick Kron

Independent Director